KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Hologic (HOLX) Share-based Compensation (2016 - 2025)

Hologic (HOLX) has disclosed Share-based Compensation for 17 consecutive years, with $26.9 million as the latest value for Q4 2025.

Quarterly Share-based Compensation fell 10.63% to $26.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $81.1 million through Dec 2025, down 3.11% year-over-year, with the annual reading at $84.3 million for FY2025, 2.43% up from the prior year.
Share-based Compensation hit $26.9 million in Q4 2025 for Hologic, up from $12.3 million in the prior quarter.
In the past five years, Share-based Compensation ranged from a high of $30.1 million in Q4 2024 to a low of $12.3 million in Q3 2025.
Historically, Share-based Compensation has averaged $19.3 million across 5 years, with a median of $17.4 million in 2021.
Biggest five-year swings in Share-based Compensation: tumbled 52.7% in 2021 and later soared 40.0% in 2023.
Year by year, Share-based Compensation stood at $18.7 million in 2021, then increased by 9.63% to $20.5 million in 2022, then skyrocketed by 40.0% to $28.7 million in 2023, then increased by 4.88% to $30.1 million in 2024, then decreased by 10.63% to $26.9 million in 2025.
Business Quant data shows Share-based Compensation for HOLX at $26.9 million in Q4 2025, $12.3 million in Q3 2025, and $13.5 million in Q2 2025.